The worlds largest pharmaceutical company made misrepresentations and concealed documents from BYU in ongoing $1 billion litigation over creation of the arthritis drug Celebrex, according to an amended complaint filed this month in U.S. District Court in Salt Lake City. BYU and biochemistry professor Daniel Simmons first filed the lawsuit against Pfizer in 2006, alleging that Pfizer predecessor ...